Impact of methamphetamine on regional metabolism and cerebral blood flow after traumatic brain injury

Neurocritical Care

Volumn 19, Issue 2, 2013, Pages 183-191

  O'Phelan, Kristine ^a   Ernst, Thomas ^b   Park, Dalnam ^c   Stenger, Andrew ^b   Denny, Katherine ^a   Green, Deborah ^d   Chang, Cherylee ^b,e   Chang, Linda ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e QUEEN S MEDICAL CENTER   (United States)

Author keywords

Adult brain injury; Alcohol and drug abuse; Blood flow; Metabolism; MRI

Indexed keywords

MAGNETOM TRIO; METHAMPHETAMINE; MIDAZOLAM; OPIATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; ASPARTIC ACID; BRAIN; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHAMPHETAMINE; MIDDLE AGED; PERFUSION IMAGING; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885191136     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9871-9     Document Type: Article

References (38)

1. Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981;44(4):285-93.
2. Langlois J, Rutland-Brown W, Thomas K. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Atlanta: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2004.
3. Corso P, Finkelstein E, Miller T, Fiebelkorn I, Zaloshnaja E. Incidence and lifetime cost of injuries in the United States. Inj Prev. 2006;12(4):212-8.
4. Andelic N, Jerstad T, Sigurdardottir S, Schanke A, Sandvik L, Roe C. Effects of acute substance use and pre-injury substance abuse on traumatic brain injury severity in adults admitted to a trauma centre. Journal of Trauma Management and Outcomes. 2012;4:6.
5. Kolakowsky-Hayner SA, Gourley EV 3rd, Kreutzer JS, Marwitz JH, Cifu DX, McKinley WO. Pre-injury substance abuse among persons with brain injury and persons with spinal cord injury. Brain Inj. 1999;13(8):571-81.
6. Corrigan JD. Substance abuse as a mediating factor in outcome from traumatic brain injury. Arch Phys Med Rehabil. 1995;76(4):302-9.
7. Parry-Jones BL, Vaughan FL, Miles CW. Traumatic brain injury and substance misuse: a systematic review of prevalence and outcomes research (1994-2004). Neuropsychological Rehabilitation. 2006;16:537-60.
8. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci. 2004;24(26):6028-36.
9. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res. 2002;114(2):65-79.
10. Villemange V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB, Ravert HT, Musachio J, McCann UD, Ricaurte GA. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally used by humans: evidence from [11C] WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neuroscience. 1998;18(1):419-27.
11. Harvey DC, Lacan G, Tanious SP, Melega WP. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra loss. Brain Res. 2000;871:259-70.
12. Chan P, Chen JH, Lee MH, Deng JF. Fatal and non-fatal methamphetamine intoxication in the intensive care unit. JToxicology Clinical Toxicology. 1994;32(2):147-55.
13. Ashwal S, Holshouser BA, Shu SK, Simmons PL, Perkin RM, Tomasi LG, Knierim DS, Sheridan C, Craig K, Andrews GH, Hinshaw DB. Predictive value of proton magnetic resonance spectroscopy in pediatric closed head injury. Pediatr Neurol. 2000;23(2):114-25.
14. Marino S, Zei E, Battaglini M, Vittori C, Buscalferri A, Bramanti P, Federico A, De Stefano N. Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. J Neurol Neurosurg Psychiatry. 2006;78(5):501-7.
15. Ross BD, Ernst T, Kreis R, Haseler LJ, Bayer S, Danielsen E, Blüml S, Shonk T, Mandigo JC, Caton W, Clark C, Jensen SW, Lehman NL, Arcinue E, Pudenz R, Shelden CH. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging. 1998;8(4):829-40.
16. Schuhmann MU, Stiller D, Skardelly M, Bernarding J, Klinge PM, Samii A, Samii M, Brinker T. Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study. J Neurotrauma. 2003;20(8):725-43.
17. Hattori N, Huang SC, Wu HM, Liao W, Glenn TC, Vespa PM, Phelps ME, Hovda DA, Bergsneider M. PET investigation of post-traumatic cerebral blood volume and blood flow. Acta Neurochir Suppl. 2003;86:49-52.
18. Ali SF, Newport GD, Slikker W Jr. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents. Ann N Y Acad Sci. 1996;801:187-98.
19. Krimer LS, Muly EC, Williams GV, Goldman-Rakic PS. Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci. 1998;1:286-9.
20. Brain Trauma Foundation & American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Management and Prognosis of Severe Traumatic Brain Injury (Part I and II). 2000;17(6/7):286.
21. Provencher S. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14:260-4.
22. Kim SG. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med. 1995;34(3):293-301.
23. Yang Y, Gu H, Zhan W, Xu S, Silbersweig DA, Stern E. Simultaneous perfusion and BOLD imaging using reverse spiral scanning at 3T: characterization of functional contrast and susceptibility artifacts. Magn Reson Med. 2002;48:278-89.
24. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med. 1998;40(3):383-96.
25. Rasband R. W.S. ImageJ. U.S. National Institutes of Health: Bethesda; 1997-2011. http://imagej.nih.gov/ij/.
26. Steiner LA, Coles JP, Johnston AJ, Czosnyka M, Fryer TD, Smielewski P, Chatfield DA, Salvador R, Aigbirhio FI, Clark JC, Menon DK, Pickard JD. Responses of posttraumatic pericontusional cerebral blood flow and blood volume to an increase in cerebral perfusion pressure. J Cereb Blood Flow Metab. 2003;23(11):1371-7.
27. Giza CC, Hovda DA. The neurometabolic cascade of concussion. J Athletic training. 2001;36(3):228-35.
28. Vespa P, Bergsneider M, Hattori N, Wu HM, Huang SC, Martin NA, Glenn TC, McArthur DL, Hovda DA. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab. 2005;25(6):763-74.
29. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2005;62(4):444-52.
30. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13(3):981-9.
31. Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Condé F, Bloch G, Hantraye P. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab. 2000;20(5):789-99.
32. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res. 2003;28(6):941-53.
33. Xu S, Zhou J, Racz J, Shi D, Roys S, Fiskum G, Gullapalli R. Early microstructural and metabolic changes following controlled cortical impact injury in rat: a magnetic resonance imaging and spectroscopy study. Journal of Neurotrauma. 2011;28:2091-102.
34. Kety SS, Schmidt CF. The determination of cerebral blood flow in man by use of nitrous oxide in low concentrations. American J of Physiology. 1945;143:53-66.
35. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA, Phelps ME, McArthur DL, Caron MJ, Kraus JF, Becker DP. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg. 1997;86(2):241-51.
36. Hattori N, Huang SC, Wu HM, Liao W, Glenn TC, Vespa PM, Phelps ME, Hovda DA, Bergsneider M. Acute changes in regional cerebral F-FDG kinetics in patients with traumatic brain injury. J of Nuclear Medicine. 2004;45:775-83.
37. Hwang J, Lyoo IK, Kim SJ, Sung YH, Bae S, Cho SN, Lee HY, Lee DS, Renshaw PF. Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users. Drug Alcohol Depend. 2006;82(2):177-81.
38. Soustiel JF, Sviri GE, Mahamid E, Shik V, Abeshaus S, Zaaroor M. Cerebral blood flow and metabolism following decompressive craniectomy for control of increased intracranial pressure. Neurosurgery. 2010;67(1):65-72.